|
Prior to joining Raven, Mr. Whelan was Vice President and Chief Financial Officer at Eos Biotechnology, where he was responsible for finance, business development, and administration. While at Eos, Mr. Whelan completed a funding round and reached agreement to merge Eos with Pharmacopeia. He also worked on collaborations with Biogen, Medarex, ICOS, and Seattle Genetics. Previously, Mr. Whelan held a number of ascending management positions at Hewlett Packard/Agilent, culminating in his tenure as Director of Corporate Development, during which he led the consummation of numerous acquisitions, investments, and collaborations with companies in the life sciences, medical devices, and computing industries. He also led the team that completed HP's first $1 billion acquisition. Mr. Whelan has a BS in Engineering from the University of California, Berkeley and an MBA from the Anderson Graduate School of Management at UCLA. | 